Company Filing History:
Years Active: 2014
Title: Michael F. Bradley: Innovator in Pharmaceutical Compounds
Introduction
Michael F. Bradley is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for various diseases.
Latest Patents
Bradley's most recent patent is titled "Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors." This patent includes compounds of Formula (I) and pharmaceutically acceptable salts thereof. The compounds are designed to inhibit cFMS and are useful in treating bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, and pain. He holds 1 patent in this area.
Career Highlights
Michael F. Bradley is currently associated with Array Biopharma Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing treatments for complex health issues.
Collaborations
Bradley has collaborated with notable colleagues, including Mark Laurence Boys and Robert Kirk DeLisle, contributing to a dynamic research environment.
Conclusion
Michael F. Bradley's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions are paving the way for new treatments that address critical health challenges.